药物信息为Aviane - 28 DAY (levonorgestrel and ethinyl estradiol tablets, USP) (Barr Laboratories Inc.): NONCONTRACEPTIVE HEALTH BENEFITS
- DESCRIPTION
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- ADVERSE REACTIONS
- OVERDOSAGE
- NONCONTRACEPTIVE HEALTH BENEFITS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- BRIEF SUMMARY PATIENT PACKAGE INSERT
- DETAILED PATIENT LABELING
- 外部链接相关的Aviane - 28 DAY (levonorgestrel and ethinyl estradiol tablets, USP) (Barr Laboratories Inc.)
The following noncontraceptive health benefits related to the use of oral contraceptives are supported by epidemiological studies which largely utilized oral contraceptive formulations containing doses exceeding 0.035 mg of ethinyl estradiol or 0.05 mg of mestranol.
Effects on menses:
- Increased menstrual cycle regularity
- Decreased blood loss and decreased incidence of iron-deficiency anemia
- Decreased incidence of dysmenorrhea
Effects related to inhibition of ovulation:
- Decreased incidence of functional ovarian cysts
- Decreased incidence of ectopic pregnancies
Effects from long-term use:
- Decreased incidence of fibroadenomas and fibrocystic disease of the breast
- Decreased incidence of acute pelvic inflammatory disease
- Decreased incidence of endometrial cancer
- Decreased incidence of ovarian cancer
- Drug Information Provided by National Library of Medicine (NLM).
